More Executive Changes At Labcorp’s Diagnostic Division

After only a few days in the position, LabCorp Diagnostics’ CEO John Ratliff has resigned to take a top executive position at an unnamed company. Ratliff, age 59, had become head of LabCorp’s diagnostic testing business effective November 1. He had formerly been CEO of Covance, LabCorp’s drug development business.

Former LabCorp President and CEO Dave King, 62, had been serving as interim head of LabCorp’s diagnostic testing business since January 1, 2019. King retired from his day-to-day executive positions at LabCorp on November 1, but is staying on as Chairman through at least the end
of next year.

LabCorp says that its diagnostics division will now be led by two individuals. Brian Caveney, MD, 46, has been named Executive Vice President and President of Diagnostics. Caveney was formerly Chief Medical Officer at LabCorp. In addition, Mark Schroeder, 58, has become Executive Vice President and President of Laboratory Operations and Global Supply Chain. Schroeder was formerly LabCorp’s Chief Supply Chain Officer.